Skip to main content
. Author manuscript; available in PMC: 2009 Feb 7.
Published in final edited form as: Regul Pept. 2007 Nov 21;146(1-3):285–292. doi: 10.1016/j.regpep.2007.11.002

Figures 1A & 1B.

Figures 1A & 1B

Immunofluorescent staining for VPAC-1 receptors (Figure 1A) and VIP (Figure 1B) in HepG2 cells. Figure 1C: Negative control, illustrating the specificity of the VPAC-1 and VIP antibodies. VIP and VPAC-1 immunoreactivities were specifically blocked with 10 ug/ml blocking peptides. Figure 1C is reflecting the specificity of VPAC-1 antibody (Blocking of VIP was similar to that of VPAC-1; data is not shown).